Status:

TERMINATED

Do You Need to Assess Myocardial Ischemia in Type 2 Diabetes

Lead Sponsor:

Hospices Civils de Lyon

Conditions:

Type 2 Diabetes

Eligibility:

All Genders

55-75 years

Phase:

NA

Brief Summary

DYNAMIT is a prospective, randomized, multicenter, open strategy trial run in 45 French hospitals. Diabetic patients with no evidence of coronary artery disease and at least 2 additional cardiovascula...

Eligibility Criteria

Inclusion

  • Patients 55 to 75 years old had type-2 diabetes and at least two of the following cardiovascular risk factors:
  • urinary albumin excretion \> 30 mg/L or \> 30 mg/24 hours,
  • treated or untreated hypertension,
  • treated or untreated lipid abnormality,
  • peripheral arterial disease,
  • history of transient ischemic accident,
  • tobacco consumption
  • familial history of premature cardiovascular disease.

Exclusion

  • History of myocardial infarction, coronary artery disease, or stroke,
  • Previous positive stress test or myocardial perfusion imaging,
  • Negative stress test or myocardial perfusion imaging within the last three years

Key Trial Info

Start Date :

December 1 2000

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2005

Estimated Enrollment :

642 Patients enrolled

Trial Details

Trial ID

NCT00627783

Start Date

December 1 2000

End Date

July 1 2005

Last Update

March 3 2008

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hopital Louis Pradel

Bron, France, 69500